Skip to main content

Research Results That Clashed – What's the Right Answer?

  • Chapter
It's Great! Oops, No It Isn't
  • 1643 Accesses

This chapter uses a series of case studies to illustrate that inconsistent research findings are all too common. The first case deals with the use of mam-mography to screen for breast cancer and how the appearance of a negative study, after a run of studies that supported the use of mammography, caused the medical community to rethink the value of mammography. Eventually after a consensus was reached that mammography could detect early cancer and save lives, doubts lingered because of the harm caused by false positive results. The second case follows the disastrous plight of the contraceptive device, Dalkon Shield. Reports claiming the Shield caused a pelvic inflammatory disease became so pervasive that the product had to be withdrawn, but the number of lawsuits drove the company into bankruptcy. However, it appears likely that its downfall may have been due to shoddy research and overzealous regulators. The final example involves aspirin use to prevent a heart attack. Using the same kind of subject (doctors) and similar designs, contrasting results between major U.S. and U.K. trials occurred. Although additional research supported the US findings of a positive effect, the FDA never approved this use of aspirin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Chapter 16 — Research Results that Clashed

Cited References

  • Alexander F, Anderson T, Brown H, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994:70;542–548.

    PubMed  CAS  Google Scholar 

  • Commentary. Letters to the editor. Cochrane review on screening for breast cancer with mam-mography. Lancet 2001:358;2164.

    Google Scholar 

  • Gotzsche P, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000:355;129–134.

    Article  PubMed  CAS  Google Scholar 

  • Kerlikowske K, Grady D, Rubin S, et al. Efficacy of screening mammography: a meta-analysis. JAMA 1995:11;149–154.

    Article  Google Scholar 

  • Mayor S. Swedish study questions mammography screening programmes. Br Med J 1999:318;621.

    CAS  Google Scholar 

  • Miller A, Baines C, To T, et al. Canadian national breast screening study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992:147;1459–1476.

    CAS  Google Scholar 

  • Nystrom L, Rutqvist L, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised studies. Lancet 1993:341;973–978.

    Article  PubMed  CAS  Google Scholar 

  • Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002:359;909–919.

    Article  PubMed  Google Scholar 

  • Shapiro S, Venet W, Strax P, et al. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982:69;349–355.

    PubMed  CAS  Google Scholar 

  • Burkman R. Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol 1981:57;269–276.

    PubMed  CAS  Google Scholar 

  • Christian C. Maternal deaths associated with intrauterine device. Am J Obstet Gynecol 1974:119;441–444.

    PubMed  CAS  Google Scholar 

  • Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001:357;89–95.

    Article  Google Scholar 

  • Farley T, Rosenberg M, Rowe P, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992:33;785–788.

    Article  Google Scholar 

  • Gareen I, Greenland S, Morgenstern H. Intrauterine devices and pelvic inflammatory disease meta analysis of published studies, 1974–1990. Epidemiol 2000:11;589–597.

    Article  CAS  Google Scholar 

  • Kromal R, Whitney C, Mumford S. The intrauterine device and pelvic inflammatory disease: the women's health study reanalyzed. J Clin Epidemiol 1991:44;109–122.

    Article  Google Scholar 

  • Mumford S, Kessel E. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings. Fertil Steril 1992:57;1151–1176.

    PubMed  CAS  Google Scholar 

  • Ory H. A review of the association between intrauterine devices and acute pelvic inflammatory disease. J Reprod Med 1978:20;200–204.

    PubMed  CAS  Google Scholar 

  • Boston Collaborative Drug Surveillance Program. Regular aspirin intake and acute myocardial infarction. Br Med J 1974:1;440–444.

    Google Scholar 

  • Hammond E, Garfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Med J 1975:2;269–271.

    PubMed  CAS  Google Scholar 

  • Hansson L, Zanchetti A, Carruthers A, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998:351;1755–1762.

    Article  PubMed  CAS  Google Scholar 

  • Hennekens C, Karlson L, Rosner B. A case-control study of regular aspirin use and coronary deaths. Circulation 1978:58;35–38.

    PubMed  CAS  Google Scholar 

  • Jick H, Miettinen O. Regular aspirin use and myocardial infarction. Br Med J 1976:1;1057.

    PubMed  CAS  Google Scholar 

  • Paganini-Hill A, Chao A, Ross R, et al. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 1989:299;1247–1250.

    CAS  Google Scholar 

  • Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 1988:296;13–16.

    Article  Google Scholar 

  • Steering Committee of the Physicians' Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing Physicians' Health Study. New Engl J Med 1988:318;262–264.

    Google Scholar 

  • Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. New Engl J Med 1989:321;129–35.

    Google Scholar 

  • The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998:351;233–241.

    Article  Google Scholar 

General References

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V

About this chapter

Cite this chapter

(2009). Research Results That Clashed – What's the Right Answer?. In: It's Great! Oops, No It Isn't. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8907-7_16

Download citation

Publish with us

Policies and ethics